Literature DB >> 26825704

Established and Emerging Treatment Options for Functional Heartburn and Chest Pain.

Jan Tack1, Tim Vanuytsel2, Ans Pauwels3.   

Abstract

OPINION STATEMENT: Functional heartburn and functional chest pain of presumed esophageal origin are characterized by symptoms suggesting an esophageal origin, but negative work-up on routine investigations, including ruling out gastroesophageal reflux disease. Visceral hypersensitivity is a potentially unifying pathophysiological concept, thought to underlie these disorders. In addition, there is important overlap with other functional disorders and psychiatric co-morbidity. This review summarizes current concepts on definition, diagnosis, and treatment options for functional heartburn and functional chest pain of presumed esophageal origin. Antidepressants are frequently used in these conditions, where they are presumed to act as neuromodulators of visceral hypersensitivity. There is a need for high-quality trials evaluating the efficacy of antidepressants and more specific neuromodulators, such as pregabalin, in functional esophageal disorders.

Entities:  

Keywords:  Antidepressants; Chest pain of esophageal origin; Functional heartburn; Gastroesophageal reflux disease; Neuromodulators; Pregabalin; Visceral hypersensitivity

Year:  2016        PMID: 26825704     DOI: 10.1007/s11938-016-0081-3

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  58 in total

1.  Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

Authors:  G M Campos; J H Peters; T R DeMeester; S Oberg; P F Crookes; S Tan; S R DeMeester; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

2.  Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial.

Authors:  Hyuk Lee; Jeong Hwan Kim; Byung-Hoon Min; Jun Haeng Lee; Hee Jung Son; Jae J Kim; Jong Chul Rhee; Young Ju Suh; Seonwoo Kim; Poong-Lyul Rhee
Journal:  Am J Gastroenterol       Date:  2010-03-23       Impact factor: 10.864

3.  Unexplained chest pain: the hypersensitive, hyperreactive, and poorly compliant esophagus.

Authors:  S S Rao; H Gregersen; B Hayek; R W Summers; J Christensen
Journal:  Ann Intern Med       Date:  1996-06-01       Impact factor: 25.391

4.  Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid.

Authors:  Michael Shapiro; Colleen Green; Jimmy M Bautista; Raniero L Peru; Isaac B Malagon; Matthew Corvo; Sara Risner-Adler; Joy N Beeler; Irina Tuchinsky; Ronnie Fass
Journal:  Am J Gastroenterol       Date:  2006-05       Impact factor: 10.864

5.  Sustained esophageal contraction: a motor correlate of heartburn symptom.

Authors:  N Pehlivanov; J Liu; R K Mittal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

6.  Patients with refractory reflux symptoms often do not have GERD.

Authors:  T V K Herregods; M Troelstra; P W Weijenborg; A J Bredenoord; A J P M Smout
Journal:  Neurogastroenterol Motil       Date:  2015-06-18       Impact factor: 3.598

7.  Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.

Authors:  Frank Zerbib; Sabine Roman; Alain Ropert; Stanislas Bruley des Varannes; Philippe Pouderoux; Ulriikka Chaput; François Mion; Eric Vérin; Jean-Paul Galmiche; Daniel Sifrim
Journal:  Am J Gastroenterol       Date:  2006-07-18       Impact factor: 10.864

8.  Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans.

Authors:  A B Gorelick; S S Koshy; F G Hooper; T C Bennett; W D Chey; W L Hasler
Journal:  Am J Physiol       Date:  1998-09

9.  Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial.

Authors:  R E Clouse; P J Lustman; T C Eckert; D M Ferney; L S Griffith
Journal:  Gastroenterology       Date:  1987-04       Impact factor: 22.682

10.  Hyperventilation and esophageal dysmotility in patients with noncardiac chest pain.

Authors:  R A Cooke; A Anggiansah; J Wang; J B Chambers; W Owen
Journal:  Am J Gastroenterol       Date:  1996-03       Impact factor: 10.864

View more
  1 in total

Review 1.  Novel Therapies for Gastroesophageal Reflux Disease: Beyond Proton Pump Inhibitors.

Authors:  Fahmi Shibli; Yoshitaka Kitayama; Ronnie Fass
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.